Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184558 | PMC |
| http://dx.doi.org/10.4088/PCC.10l01081 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Aripiprazole-induced Parkinsonism with pregabalin as a confounder.
Acta Neurol Belg
October 2021
Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, 221005, India.
Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
Neurologist
January 2017
*Unité des Troubles du Mouvement André Barbeau †Division of Neurology, Centre Hospitalier de l'Université de Montréal Departments of ‡Neuroscience §Pharmacology, Université de Montréal ∥Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Article Synopsis
- Aripiprazole, an antipsychotic known for its partial agonist activity at dopamine D2 receptors, has been found to potentially cause movement disorders despite expectations of fewer side effects compared to typical antipsychotics.
- Researchers reviewed patient records from a movement disorder clinic to investigate reports of aripiprazole-induced symptoms, focusing on their psychiatric history and medication details.
- The study identified 14 cases of movement disorders like parkinsonism and tardive dyskinesia related to aripiprazole, highlighting the need for clinicians to be vigilant about this possible adverse effect when prescribing the medication.
A Review of Differences in Clinical Characteristics between Tardive Syndrome Induced or Improved by Aripiprazole Treatment.
Acta Neurol Taiwan
September 2016
Department of Psychiatry, Tsyr-Huey Mental Hospital, Kaohsiung Jen-Ai's Home, Taiwan.
Introduction: Tardive syndrome is a troublesome complication secondary to the long-term usage of antipsychotic medication. At present, there is a lack of effective treatment for tardive syndrome. Aripiprazole has been used in the treatment of tardive syndrome, with some reports of a good response.
View Article and Find Full Text PDF[Aripiprazole, gambling disorder and compulsive sexuality].
Encephale
June 2016
Service d'addictologie, CHU Félix-Guyon, route de Bellepierre, 97405 Saint-Denis cedex, Réunion.
Introduction: Aripiprazole, an atypical or second-generation antipsychotic, is usually well tolerated. It is an approved treatment for schizophrenia and mania in bipolar disorder type 1. Unlike the other antipsychotics, it has high affinity agonist properties for dopamine D2 and D3 receptors.
View Article and Find Full Text PDFOral aripiprazole-induced severe hypoglycemia.
Ther Drug Monit
June 2012
Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, India.
This case report highlights a very rare adverse drug reaction caused by oral aripiprazole resulting in severe hypoglycemia. A 72-year-old-male patient suffering from Parkinson disease on prolonged carbidopa plus levodopa combination therapy (carbidopa 25 mg plus levodopa 100 mg, thrice daily) for 1.3 years was recently diagnosed with psychosis and was initiated 10 mg/day oral aripiprazole.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!